63 results on '"Stöhr, R"'
Search Results
2. Molecular characterization of upper urinary tract urothelial carcinoma and paired bladder cancer recurrences
3. NV centres by vacancies trapping in irradiated diamond: experiments and modelling
4. Influence of Individual Personality Traits of the Reader on Visual Assessment of Left Ventricular Ejection Fraction: Another Reason to Abandon Visual Assessment
5. Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling
6. All-optical and microwave-free detection of Meissner screening using nitrogen-vacancy centers in diamond
7. Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders
8. 758P Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC)
9. 28P Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancer
10. Sponge-Associated Bacteria: General Overview and Special Aspects of Bacteria Associated with Halichondria panicea
11. Status der Verfügbarkeit und Anwendung von „next generation sequencing“ (NGS) beim Harnblasenkarzinom – eine Umfrage in der Arbeitsgemeinschaft Uropathologie
12. Development of a coherent spin photon interface for quantum repeaters using NV centers in diamond
13. AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis
14. Microwave-Assisted Cross-Polarization of Nuclear Spin Ensembles from Optically Pumped Nitrogen-Vacancy Centers in Diamond
15. Genexpressionanalyse von Mammakarzinomen mittels Prosigna® Assay (NanoString Technologies, Seattle WA) im klinischen Alltag und Einfluss auf die Entscheidung des Onkologen hinsichtlich Systemtherapie
16. 6. Symposium des Deutschen Forschungsverbunds Blasenkarzinom
17. Prognostic impact of a 12-gene progression score in non-muscle invasive bladder cancer: A prospective multicenter validation study
18. Glucose-dependent insulinotropic peptide secretion is induced by inflammatory stimuli in an interleukin-1-dependent manner in mice
19. Bericht vom 5. Symposium des Deutschen Forschungsverbunds Blasenkarzinom
20. Molekulare Klassifikation des Harnblasenkarzinoms
21. 757 High ESR1 and PGR mRNA expression determined by RT-qPCR in FFPE routine tissue samples predicts superior disease specific survival in non-muscle invasive bladder cancer
22. ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice
23. Zu einigen gefährlichen waffentechnischen Entwicklungen in den imperialistischen Staaten
24. Kolorimetrische Bestimmung der Pikrinsäure in Pikraten organischer Basen
25. The GLP-1 metabolite (9 – 37) improves myocardial function in the TAC model by reducing myocardial hypertrophy and improving glucose uptake
26. EGFR Mutationsstatus in einem großen kaukasischen Patientenkollektiv aus Europa mit NSCLC: Daten aus der täglichen Praxis
27. Personalisierte Uroonkologie auf Grundlage einer molekularen Uropathologie
28. Das Harnblasenkarzinom im Fokus
29. Enhancing the spin properties of shallow implanted nitrogen vacancy centers in diamond by epitaxial overgrowth
30. Optical detection of a single rare-earth ion in a crystal
31. Comparison of plasma methylated SEPT9 screening marker in both left- and right-sided colon cancer to GFOBT and CEA results
32. Harnblasenkarzinom in jungen Jahren bei Vater und Sohn*
33. 628 MICRORNAS ARE REPRODUCIBLY DEREGULATED IN PROSTATE CARCINOMA AND ARE POTENTIAL REGULATORS OF SIGNAL TRANSDUCTION PATHWAYS LIKE PI3-KINASE OR MAP-KINASE PATHWAYS
34. Blasenkarzinom – Update
35. KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy
36. EMMPRIN (CD147)
37. Enhanced photoluminescence from self-organized rubrene single crystal surface structures
38. 722 SPECIFIC PROTEIN PATTERNS CHARACTERIZE METASTATIC POTENTIAL IN ADVANCED BLADDER CANCER
39. 824 PI3K/AKT/MTOR SIGNALING IN UROTHELIAL CARCINOMA AND ITS VALUE IN CANCER THERAPY
40. Symposium des Deutschen Forschungsverbundes Blasenkarzinom e.V.
41. Use of multidrug-resistance gene (MDR1) expression levels to predict outcome to adjuvant cisplatin/gemcitabine based chemotherapy in patients with with locally advanced urothelial cancer
42. Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trial
43. EMMPRIN (CD147)
44. Präkanzerosen des Urothels
45. Das plasmazytoide Urothelkarzinom
46. Definition spezifischer Proteinmuster für fortgeschrittene (metastasierte) Harnblasentumoren zur individuellen Prognosebestimmung und Therapiewahl
47. 824 Clinical, histopathological and molecular characterization of early onset bladder cancer
48. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract
49. Molecular Basis of Carcinogenesis, Abstract 277–285, Symposium
50. Molecular Pathology, Abstract 1–24, Study Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.